Healthcare / Drug Manufacturers - GeneralUpdated 2026-05-10 22:07 UTC

NSE/KOPRAN stock hub

NSE/KOPRAN has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

NSE/KOPRANis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

7.8B

National Stock Exchange of India

Market data

Live price

Current market quote for this ticker.

Current price

NSE/KOPRAN

In the news

Latest news · NSE/KOPRAN

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 24.9P50 32.4P75 45.7

Trailing P/E47.1

P25 24.8P50 35.9P75 56.9

ROEn/a

P25 6.3P50 13.6P75 18.1

ROIC4.6

P25 4.1P50 10.3P75 17.9

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All NSE/KOPRAN market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

194

Groups with data

Currency

INR

Showing 194 of 194 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	India
Country code	IN
Employees	1,024
Employees Change	182%
Employees Change Percent	21.62
Enterprise value	INR 9B
Exchange	National Stock Exchange of India
Financial currency	INR
First seen	2026-05-10
Industry	Drug Manufacturers - General
Isin	INE082A01010
Last refreshed	2026-05-10
Market cap	INR 7.8B
Price	INR 162
Price currency	INR
Rev Per Employee	6,052,425.78x
Sector	Healthcare
Sic	2834
Symbol	nse/KOPRAN
Website	https://www.kopran.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	2.12%
EV Earnings	54.34x
EV/EBIT	23.15x
EV/EBITDA	16.21x
EV/Sales	1.45x
P/B ratio	1.56x
P/E ratio	47.11x
P/S ratio	1.26x
PE Ratio10 Y	17.89x
PE Ratio3 Y	29.96x
PE Ratio5 Y	24.91x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	6.27%
EBITDA Margin	8.95%
Gross margin	33.48%
Gross Profit	INR 2.1B
Gross Profit Growth	-6.83%
Gross Profit Growth Q	4.44%
Gross Profit Growth3 Y	2.06%
Gross Profit Growth5 Y	2.27%
Net Income	INR 165.4M
Net Income Growth	-65.17%
Net Income Growth Q	-10.15%
Net Income Growth Years	0%
Net Income Growth3 Y	-23.33%
Net Income Growth5 Y	-20.28%
Pretax Margin	3.67%
Profit Margin	2.67%
Profit Per Employee	INR 161,553
Profitable Years	10
Roa5y	7.1
Roe5y	14.28
ROIC	4.56
Roic5y	11.16

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	12.64%
Cagr15y	14.95%
Cagr1y	-9.24%
Cagr20y	4.23%
Cagr3y	5.18%
Cagr5y	-2.03%
Div CAGR10	7.18%
Div CAGR3	0%
Div CAGR5	0%
EPS Growth	-65.32
EPS Growth Q	-10.23
EPS Growth Years	0
EPS Growth3 Y	-23.53
EPS Growth5 Y	-22.06
Revenue Growth	-3.66x
Revenue Growth Q	16.87x
Revenue Growth Quarters	1x
Revenue Growth Years	3x
Revenue Growth3 Y	4.48x
Revenue Growth5 Y	7.13x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Cash	INR 371.4M
Debt	INR 1.6B
Debt EBITDA	INR 2.83
Debt Equity	INR 0.31
Equity	INR 5B
Interest Coverage	4.6
Net Cash	INR -1.2B
Net Cash By Market Cap	INR -15.36
Net Debt EBITDA	INR 2.16
Net Debt Equity	INR 0.24
Tangible Book Value	INR 4.7B
Tangible Book Value Per Share	INR 98.36
WACC	7.66

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-0.36%
Dividend Growth	0%
Dividend Growth Years	0%
Dividend per share	INR 3
Dividend Years	6
Dividend Yield	1.83%
Ex Div Date	2025-09-04
Last Dividend	INR 3
Payout Frequency	Annual

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	228.69%
1Y total return	-9.23%
200-day SMA	150.3
3Y total return	16.36%
50-day SMA	137.4
50-day SMA vs 200-day SMA	50under200
5Y total return	-9.72%
All Time High	370.5
All Time High Change	-56.39%
All Time High Date	2021-12-29
All Time Low	6
All Time Low Change	2,592.5%
All Time Low Date	2008-11-20
ATR	7.22
Beta	0.76
Ch YTD	7.39
High	166.8
High52	212.6
High52 Date	2025-06-12
High52ch	-24.01%
Low	161
Low52	107
Low52 Date	2026-03-30
Low52ch	50.98%
Ma50ch	17.62%
Price vs 200-day SMA	7.52%
RSI	61.81
RSI Monthly	47.23
RSI Weekly	57.93
Sharpe ratio	-0.22x
Sortino ratio	-0.21
Total Return	1.47%
Tr YTD	7.39
Tr15y	708.73%
Tr1m	20.27%
Tr1w	-1.23%
Tr3m	15.34%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	INR 388.4M
Operating Income Growth	-43.42
Operating Income Growth Q	-16.37
Operating Income Growth3 Y	-13.05
Operating Income Growth5 Y	-11.02
Operating margin	6.27

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	24,227,155%
Shares Insiders	10.69%
Shares Institutions	0.23%
Shares Qo Q	0.46%
Shares Yo Y	0.36%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Average Volume	295,009.85x
Bv Per Share	104
Ch10y	205.4
Ch15y	651.4
Ch1m	20.27
Ch1w	-1.23
Ch1y	-10.8
Ch20y	112.6
Ch3m	15.34
Ch3y	11.8
Ch5y	-15.09
Ch6m	1.95
Change	-1.79%
Change From Open	-1.91
Close	164.5
Days Gap	0.13
Depreciation Amortization	166,341,250
Dollar Volume	28,047,341.7
Earnings Date	2026-05-19
EBIT	INR 388.4M
EBITDA	INR 554.8M
EPS	INR 3.42
F Score	1
Fiscal Year End	March
Founded	1,958
Graham Number	89.52388
Graham Upside	-44.58
Income Tax	INR 61.8M
Is Primary Listing	0
Last Earnings Date	2026-01-22
Last Report Date	2025-12-31
Lynch Fair Value	INR 17.15
Lynch Upside	-89.39
Ma150	144
Ma150ch	12.15%
Ma20	159.2
Ma20ch	1.47%
Next Earnings Date	2026-05-19
Open	164.7
Payment Date	2025-10-11
Position In Range	9.5
Price Date	2026-05-08
Price EBITDA	INR 14.05
Ptbv Ratio	1.64
Relative Volume	0.6x
Revenue	6,197,684,000x
Tax By Revenue	1x
Tax Rate	27.18%
Tr20y	128.79%
Tr6m	1.95%
Volume	173,614

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

NSE/KOPRAN dividend yield, growth & safety

Yield, payout sustainability, and the multi-year growth streak.

Dividend yield

+1.8%

$3.00 annual per share

Payout ratio

n/a

Share of earnings returned as dividends. Below 60% is generally sustainable.

5Y dividend CAGR

0.0%

0 consecutive years of growth

Total shareholder yield

+1.5%

Next ex-dividend date: 2025-09-04

Performance

NSE/KOPRAN stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns NSE/KOPRAN?

Insider, institutional, and short-interest positioning.

Institutional ownership

+0.2%

Share of float held by funds and institutions

Insider ownership

+10.7%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

+0.4%

Negative means the company is buying back shares.

Technical

NSE/KOPRAN momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

61.8

Neutral momentum band

Price vs 200-day MA

+7.5%

50/200-day relationship not available

Beta (5Y)

0.76

Less volatile than the market

Sharpe ratio

-0.22

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About NSE/KOPRAN

Hub-level FAQ points readers to the deeper analysis pages.

What is the current nse/KOPRAN stock rating?

nse/KOPRAN is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full nse/KOPRAN analysis?

The full report lives at /stocks/nse/KOPRAN/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for nse/KOPRAN?

The latest report frames nse/KOPRAN around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the nse/KOPRAN page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.